NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Antihistamines, Amantadine and Evolution of COVID-19
Antihistamines, Amantadine and Evolution of COVID-19

NCT05504057

RecruitingN/A

Sponsor: Consorci Sanitari de Terrassa

Conditions: COVID-19

Interventions: Antihistamine, Amantadine

Countries: Spain

The rates of symptomatic COVID19 infection, hospital admission among COVID19 cases and survival would be quantified in patiens chronically treated with antihistamines or amantadine, with the aim of determining the role of antihistamines and amantadine in the evolution of COVID19.

Eligibility overview

Sex: ALL

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria: Patients having chronic treatment with antihistamines or amantadine -

Exclusion Criteria: None

\-
Locations (2)
  • Terrassa, Barcelona, Spain
  • Terrassa, Barcelona, Spain